Avenu Medical Overview

  • Founded

  • 2010

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 40

Employees
  • Latest Deal Type

  • M&A

Avenu Medical General Information

Description

Developer of a vascular therapeutic device created to pursue unmet clinical needs in the vascular access markets. The company's device is an innovative, image-guided, single catheter system used to percutaneously create an arteriovenous fistula for hemodialysis access, thereby enabling hospitals to treat patients with chronic kidney diseases.

Contact Information

Website
www.avenumedical.com
Formerly Known As
Caymus Medical
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Parent Company
Medtronic
Primary Office
  • 27123 Calle Arroyo
  • Suite 2101
  • San Juan Capistrano, CA 92675
  • United States
+1 (949) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avenu Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 000.00 Completed Generating Revenue
6. Debt - PPP 03-May-2020 00000 000.00 Completed Generating Revenue
5. Later Stage VC 31-Oct-2018 0000 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 15-Feb-2017 000.00 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series B) 15-Dec-2015 00.00 000.00 000.00 Completed Startup
2. Early Stage VC (Series A) 03-May-2011 $1.44M $2.44M 00.000 Completed Startup
1. Seed Round 28-Sep-2010 $1M $1M 000 Completed Startup
To view Avenu Medical’s complete valuation and funding history, request access »

Avenu Medical Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C 0,000,000 00.000000 00 00 00 00 00.00
Series B 0,000,000 00.000000 00 00 00 00 00.00
Series A 5,500,000 $0.001000 $1 $1 1x $1 25.85%
Series S 2,500,000 $0.001000 $0.4 $0.4 1x $0.4 11.75%
To view Avenu Medical’s complete cap table history, request access »

Avenu Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a vascular therapeutic device created to pursue unmet clinical needs in the vascular access markets. The co
Therapeutic Devices
San Juan Capistrano, CA
40 As of 2020
000.00
0&0 000.00

000000

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqu
00000000 0000000
Marlborough, MA
00 As of 0000
00000
000 0000-00-00
00000000000 00000

000000

rehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excep
00000000000 0000000
Tel Aviv, Israel
00 As of 0000
0000
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Avenu Medical Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CardioFocus Venture Capital-Backed Marlborough, MA 00 00000 00000000000 00000
00000000 0000000 0 Venture Capital-Backed Tel Aviv, Israel 00 0000 00000000000 0000
00000000 Formerly VC-backed Mason, OH 0000 0000 00000000 0000
0000000000000 Corporation New York, NY 000 000.00 000000 - 000 000.00
00000 0000000 Formerly VC-backed Irvine, CA 0000 00000 00000000 00000
You’re viewing 5 of 18 competitors. Get the full list »

Avenu Medical Patents

  • 134

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 17

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Avenu Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210177508-A1 Devices and methods for the creation of an inter-atrial shunt for the treatment of congestive heart failure Pending 12-Dec-2019 0000000000
EP-3829457-A4 Fixation of vessels for percutaneous fistula creation Pending 03-Aug-2018 00000000000 0
EP-3829457-A1 Fixation of vessels for percutaneous fistula creation Pending 03-Aug-2018 00000000000
US-20200038026-A1 Fixation of vessels for percutaneous fistula creation Active 03-Aug-2018 000000000
US-11083460-B2 Fixation of vessels for percutaneous fistula creation Active 03-Aug-2018 A61B17/1227
To view Avenu Medical’s complete patent history, request access »

Avenu Medical Executive Team (7)

Name Title Board Seat Contact Info
Mark Ritchart Co-Founder, Chief Executive Officer & President
Jeffrey Hull Co-Founder
David Campbell Vice President, Quality Assurance and Regulatory Affairs
You’re viewing 3 of 7 executive team members. Get the full list »

Avenu Medical Board Members (5)

Name Representing Role Since
Mark Ritchart Avenu Medical Co-Founder, Chief Executive Officer & President 000 0000
You’re viewing 1 of 5 board members. Get the full list »

Avenu Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avenu Medical Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Pond Capital Venture Capital Minority 000 0000 000000 0
To view Avenu Medical’s complete investors history, request access »

Ready to get started?

Request a free trial